Market and company headlines
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(0.54) per share. This is a 56.1 percent increase over losses of $(1.23) per share from the same period last year. The company reported $0.00 in sales this
Benzinga·13:03·Last MonthPMCB▼−2.0%